Epigenetic repression of PDZ-LIM domain-containing protein 2: implications for the biology and treatment of breast cancer.
about
IGF-1 Receptor and Adhesion Signaling: An Important Axis in Determining Cancer Cell Phenotype and Therapy ResistanceMethylation of the CpG sites only on the sense strand of the APC gene is specific for hepatocellular carcinomaGlobal Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target.DNA methylation-dependent repression of PDZ-LIM domain-containing protein 2 in colon cancer and its role as a potential therapeutic targetHuman T-cell lymphotropic virus: a model of NF-κB-associated tumorigenesisEpigenetic therapy for breast cancer.Oncovirus Kaposi sarcoma herpesvirus (KSHV) represses tumor suppressor PDLIM2 to persistently activate nuclear factor κB (NF-κB) and STAT3 transcription factors for tumorigenesis and tumor maintenance.NF-κB and cancer: a paradigm of Yin-Yang.Differential roles of STAT3 in the initiation and growth of lung cancerThe tumor suppressor gene WWOX links the canonical and noncanonical NF-κB pathways in HTLV-I Tax-mediated tumorigenesisNF-κB1 p105 suppresses lung tumorigenesis through the Tpl2 kinase but independently of its NF-κB function.Combined Proteomics and Transcriptomics Identifies Carboxypeptidase B1 and Nuclear Factor κB (NF-κB) Associated Proteins as Putative Biomarkers of Metastasis in Low Grade Breast CancerPDLIM2 restricts Th1 and Th17 differentiation and prevents autoimmune disease.Epigenetic repression of PDZ-LIM domain-containing protein 2 promotes ovarian cancer via NOS2-derived nitric oxide signaling.Kaposi's sarcoma herpesvirus (KSHV) microRNA K12-1 functions as an oncogene by activating NF-κB/IL-6/STAT3 signaling.PDLIM2 regulates transcription factor activity in epithelial-to-mesenchymal transition via the COP9 signalosome.Prioritization of SNPs for genome-wide association studies using an interaction model of genetic variation, gene expression, and trait variationEpigenetic up-regulation of leukemia inhibitory factor (LIF) gene during the progression to breast cancer.Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma.Regulation of epithelial proliferation by tight junction proteins.PDLIM2 suppression efficiently reduces tumor growth and invasiveness of human castration-resistant prostate cancer-like cells.Essential function for PDLIM2 in cell polarization in three-dimensional cultures by feedback regulation of the β1-integrin-RhoA signaling axis.Molecular determinants of PDLIM2 in suppressing HTLV-I Tax-mediated tumorigenesis.Lithium promotes neural precursor cell proliferation: evidence for the involvement of the non-canonical GSK-3β-NF-AT signaling.PDLIM2 expression is driven by vitamin D and is involved in the pro-adhesion, and anti-migration and -invasion activity of vitamin D.Myeloid STAT3 Promotes Lung Tumorigenesis by Transforming Tumor Immunosurveillance into Tumor-Promoting Inflammation.
P2860
Q26802042-43613BDA-5CA1-47B9-97BB-14AF1F493149Q28743228-1066FB58-A7BC-4A67-977A-BE76379C72C8Q33809716-0F96232A-9410-4F00-BF8B-4D2F29D78792Q34412280-E8DB6549-6DB8-4C23-A570-449EE1976E2DQ35090534-FC613C52-F5E6-4359-9D0C-4546A56E9447Q35162148-7B43F345-F01A-482D-A775-3CA1BABCC62BQ35199327-A5312D37-B8C8-4EC5-889D-5ADC23C45BE9Q35232248-B9028291-4679-4218-AE33-7766B3E00F35Q35288058-1AC0DEB3-8FE5-4B0A-A984-96E3E1196CDBQ35868351-9A43B4B1-8753-4B9C-961C-A674D9560D92Q35994472-A1690AAB-C37A-42EA-A48E-759A6A6E6917Q36103894-E4B351BD-A84B-47FD-B315-FE84073094D3Q36527226-8D7E8405-621C-42B3-A87A-5BD011C432D1Q36738846-C493E7CA-2FDF-4A61-A5A2-8FCE49800A6EQ37362933-F310CDA9-9A83-4A65-88EA-C7AAB82C8784Q37416507-20926794-5271-47AD-B7D6-768B4AC865F0Q37461909-9E9E5DD5-F955-40FD-9036-9DC88EB6C31FQ37599413-AF3F5ED8-ADE5-446F-ADDF-297262D00D38Q37683382-32856DDE-26AE-4ECC-8454-9DA3456CA6DBQ38021500-A7CEA269-E3A9-45DD-BFFD-370D94448190Q38825075-2F3FC7D2-213F-46D2-BE59-0E26F95BD2F2Q38991274-28F676D0-53BF-4A78-BF38-2A2C053701F8Q41566034-B2966B22-AFFE-4861-B3D1-47B528F56920Q41774912-D670BCFD-BE95-47A8-AA94-FA287CB21C6EQ51069588-E45304F5-D3C2-42B5-B414-D09455C1A0FAQ51176869-A328D65C-5AA4-441B-B5BF-A61629541C47
P2860
Epigenetic repression of PDZ-LIM domain-containing protein 2: implications for the biology and treatment of breast cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Epigenetic repression of PDZ-L ...... nd treatment of breast cancer.
@ast
Epigenetic repression of PDZ-L ...... nd treatment of breast cancer.
@en
type
label
Epigenetic repression of PDZ-L ...... nd treatment of breast cancer.
@ast
Epigenetic repression of PDZ-L ...... nd treatment of breast cancer.
@en
prefLabel
Epigenetic repression of PDZ-L ...... nd treatment of breast cancer.
@ast
Epigenetic repression of PDZ-L ...... nd treatment of breast cancer.
@en
P2093
P2860
P356
P1476
Epigenetic repression of PDZ-L ...... nd treatment of breast cancer.
@en
P2093
Gutian Xiao
Shi-Yuan Cheng
Zhaoxia Qu
P2860
P304
11786-11792
P356
10.1074/JBC.M109.086561
P407
P577
2010-02-25T00:00:00Z